Fig. 1
From: MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentations
Severe involvement of eyelids at the admission into the Dept. (a), after pulse therapy with steroids (b) and during treatment with IVIg, Cyclosporine A and hydroxychloroquine (c)